Abstract
ANABOLIC steroids have been noted to increase survival time in dystrophic mice, Jax/129 (dydy), but the disease syndrome was not otherwise altered. Testosterone propionate did not possess this ability1,2. It was of interest to evaluate an anabolic steroid, 17-α-methylandrostene-5-diol-3β-17β-dienanthoylacetate (MADD), which has a prolonged period of activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Dowben, R. M., Nature, 184, 1966 (1959).
Dowben, R. M., and Gordon, P., Fed. Proc., 20, 302 (1961).
Coleman, D. L., and West, W. T. J., J. Nutr., 73, 273 (1961).
Hall, C. E., Hall, O., and Nevis, A. H., Amer. J. Physiol., 196, 110 (1959).
Pope, R. S., and Murphy, E. D., Amer. J. Physiol., 199, 1097 (1960).
Miller, J. R., Wood, A. J., and Gibson, W. C., Nature, 190, 552 (1961).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
BORGMAN, R. Increased Survival-time in Dystrophic Mice treated with Methylandrostenediol Dienanthoylacetate. Nature 197, 1304–1305 (1963). https://doi.org/10.1038/1971304b0
Issue Date:
DOI: https://doi.org/10.1038/1971304b0
This article is cited by
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
